Reassess the diagnosis of Alzheimer's Disease (AD) in patients treated withanti-cholinesterases dispensed by High Cost Drug stores (Exceptional DrugsProgram). This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.